Skip to main content
Show full summary

Lord Mendelsohn to ask Her Majesty's Government what assessment they have made of (1) the risks to, and (2) the most effective treatment and vaccination options for, blood cancer patients in relation to COVID-19; and what discussions they have had with health agencies on this subject.  HL11894

Question HL11894: tabled on 7 January 2021 and due for answer by 21 January 2021

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

To ask Her Majesty's Government what assessment they have made of (1) the risks to, and (2) the most effective treatment and vaccination options for, blood cancer patients in relation to COVID-19; and what discussions they have had with health agencies on this subject.
Legend for business item text
Item that is new or altered.
[I] Indicates that the member concerned has a relevant registered interest.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.